 |
8 Diseases |  |
1 Trial |
|
1 Trial |  |
1 News |  |
- | Alpharen (fermagate) / OPKO Health, Auryxia (ferric citrate) / Japan Tobacco, Akebia Therap, Velphoro (sucroferric oxyhydroxide) / Fresenius Kabi, Vifor, Kissei
Retrospective data, Journal: Using iron-based phosphate binders in phosphate reduction and anemia improvement in patients receiving dialysis: a meta-analysis of randomized controlled trials. (Pubmed Central) - Jan 21, 2022
Other IBPBs, such as fermagate and SBR759, remained poorly understood due to the limited number of studies. Further trials are required to assess the effect of IBPBs on the risk of cardiovascular events and all-cause mortality.